LCD/NCD Portal
Automated World Health
NCD160.20
TRANSFER FACTOR FOR TREATMENT OF MULTIPLE SCLEROSIS
Effective Date of this Version
• This is a longstanding national coverage determination.
• The effective date of this version has not been posted.
Benefit Category
• Incident to a physician's professional Service
• Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.
Indications and Limitations of Coverage
• Transfer factor is the dialysate of an extract from sensitized leukocytes which increases cellular immune activity in the recipient.
• It is NOT covered as a treatment for multiple sclerosis because its use for the purpose is still experimental.